Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
New clues to treating deadly skin cancer
Small clinical trial finds two forms of immunotherapy may be better than one for treating metastatic melanoma
1.2 million Dream Team explore immunotherapy
Fred Hutchinson Cancer Research Center’s Drs. Cassian Yee, Phillip Greenberg and Stan Riddell join Stand Up to Cancer's three-year, international translational cancer research project
Sixth-grade scientists partner with Center researchers to tackle cancer
Aided by six Hutchinson Center 'doctor partners,' local grade schoolers explore possible cancer cures, visit campus
Investigational immunotherapy halts advanced melanoma
Cassian Yee study shows progress in using patients' own tumor-fighting cells to knock back late-stage skin cancer
Yee Lab’s McIntyre wins $10,000 research scholar grant
Amanda Claire McIntyre will use the national award from the Joanna M. Nicolay Melanoma Foundation to complete her doctorate in the UW’s Molecular & Cellular Biology program
Immunologists’ ‘team science’ honored
Collaborative achievements in T-cell immunotherapies cited
Melanoma immunologists net $525,000
Yee, Riddell, Greenberg strategize to enhance T-cell survival, expansion
Sarcoma expert leads new research program
Robin Jones heads novel molecular targeting, therapy efforts
$10 million bolster for immunotherapy research
Challenge gift will fund research that harnesses the immune system to fight cancer
Shore Run/Walk: A way to give back
Reaffirm your dedication to the Center by running or walking for cancer research
Patient's cloned T cells kill tumors
Case is first to show safety and effectiveness of using infection-fighting T cells alone to put late-stage melanoma into long-term remission
Patient's own infection-fighting T cells put late-stage melanoma into long-term remission — without chemotherapy or radiation
Case is first to show safety and effectiveness of using cloned cells alone to kill tumors
Reaping the rewards of synergistic research
Synergy Fund supports two pilot projects involving scientists from separate labs working in innovative partnerships
Wellcome funds for translational research
Clurman, Yee receive 5-year Burroughs Wellcome Fund awards for novel cancer-treatment research